Novartis delivered sales growth and core margin expansion in Q3; raised FY core operating income guidance
Ad hoc announcement pursuant to Art. 53 LR Third quarter Q3 net sales grew +4% (cc¹, +4% USD),…
Kuehne+Nagel Q1 2026 results beat expectations
The Kuehne+Nagel Group generated a net turnover of CHF 5.6 billion in the first quarter of 2026. EBIT…